0001136261-21-000208.txt : 20210902
0001136261-21-000208.hdr.sgml : 20210902
20210902160835
ACCESSION NUMBER: 0001136261-21-000208
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210901
FILED AS OF DATE: 20210902
DATE AS OF CHANGE: 20210902
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DALESANDRO MARGARET
CENTRAL INDEX KEY: 0001208853
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-22245
FILM NUMBER: 211233319
MAIL ADDRESS:
STREET 1: ONCOSEC MEDICAL INCORPORATED
STREET 2: 24 NORTH MAIN STREET
CITY: PENNINGTON
STATE: NJ
ZIP: 08534
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SEELOS THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001017491
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 870449967
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 PARK AVENUE
STREET 2: 2ND FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: (646) 293-2100
MAIL ADDRESS:
STREET 1: 300 PARK AVENUE
STREET 2: 2ND FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
FORMER COMPANY:
FORMER CONFORMED NAME: APRICUS BIOSCIENCES, INC.
DATE OF NAME CHANGE: 20100914
FORMER COMPANY:
FORMER CONFORMED NAME: NEXMED INC
DATE OF NAME CHANGE: 19970311
4
1
ownership.xml
X0306
4
2021-09-01
0
0001017491
SEELOS THERAPEUTICS, INC.
SEEL
0001208853
DALESANDRO MARGARET
C/O SEELOS THERAPEUTICS, INC.
300 PARK AVENUE, 2ND FLOOR
NEW YORK
NY
10022
1
0
0
0
Stock Option (right to buy)
2.16
2021-09-01
4
A
0
42000
0.00
A
2031-09-01
Common Stock
42000
42000
D
One-third of the shares subject to the option shall vest on September 1, 2022, and 1/36th of the shares subject to the option shall vest monthly thereafter, subject to the Reporting Person's continued service to the Issuer through each such vesting date.
/s/ Margaret Dalesandro, Ph.D.
2021-09-02